We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Catalent Biologics Adds New Technology Platform

News   Jul 09, 2015

 
Catalent Biologics Adds New Technology Platform
 
 
 

RELATED ARTICLES

Rockland Immunochemicals, Inc. CSO Opines “Benefits of Polyclonal Antibodies” in Peer-reviewed Article

News

Dr. Carl Ascoli, Chief Science Officer at Rockland, and Dr. Birte Aggeler, Director of Antibody Development at Bio-Techne, have composed a review article on the pros and cons of polyclonal, conventional monoclonal, and recombinant monoclonal antibodies.

READ MORE

A Powerful Approach for Stopping Ebola Outbreaks

News

A one-two punch of powerful antibodies may be the best way to stop Ebola virus. Recent findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.

READ MORE

Children are Highly Vulnerable to Health Risks of a Changing Climate

News

Authors recommend priority changes to reflect the vulnerability of children to climate-change related health challenges.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE